Načítá se...

(18)F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer

PURPOSE: In bone-metastatic breast cancer patients, there are no current imaging biomarkers to identify which patients have worst prognosis. The purpose of our study was to investigate if skeletal tumor burden determined by (18)F-Fluoride PET/CT correlates with clinical outcomes and may help define...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Brito, Ana E., Santos, Allan, Sasse, André Deeke, Cabello, Cesar, Oliveira, Paulo, Mosci, Camila, Souza, Tiago, Amorim, Barbara, Lima, Mariana, Ramos, Celso D., Etchebehere, Elba
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482633/
https://ncbi.nlm.nih.gov/pubmed/28415595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16418
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!